Current Treatment of 1L Hodgkin Lymphoma

University of Miami Sylvester Comprehensive Cancer Center

C. Moskowitz

ESMO 2024 Summary: Updates in the Treatment of MCL

2024 ESMO Annual Meeting Insights Hub

G. Hess

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Indy Hematology Review

S. Smith

Standards of Care and Future Directions in FL

Martin Dreyling

Top 5 Lymphoma Abstracts From ASH

Jennifer Amengual

Treatment Updates and Management of Hodgkin Lymphoma

Integrity CE

A. Niu, D. Wallace, M. Cortese

Treatment Updates and Management of Non-Hodgkin Lymphomas

Integrity CE

D. Wallace, M. Cortese

CAR T-Cell Therapy in Autoimmune Disorders

Vanderbilt University Medical Center (VUMC)

O. Oluwole

Bispecifics for LBCL: Guidance for Management of Toxicities in the C…

UChicago Medicine

J. Crombie

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

UChicago Medicine

G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu

ESMO 2024 Summary: Primary CNS Lymphoma - Updated ESMO and EHA Guide…

2024 ESMO Annual Meeting Insights Hub

A. Ferreri

Cutaneous Lymphoma 101: Overview on Diagnosis, Staging and Prognosis

Basem William

Therapeutic Advances in T-Cell Lymphoma in 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Barta

MZL: Current Management and Emerging Therapeutics

University of Miami Sylvester Comprehensive Cancer Center

I. Lossos

Novel Therapeutics for T-Cell Lymphoma: Navigating Regulatory Pitfal…

UChicago Medicine

S. Iyer

DLBCL: Principles of Diagnosis, Prognosis and Staging

University of Colorado Division of Hematology

C. Pearson

Practical Aspects of Bispecifics in NHL: Supportive Care and Minimiz…

UChicago Medicine

K. Kelly

Epigenetics in T-cell Lymphoma: From Promise to Practice

UChicago Medicine

E. Marchi